Chong Susan C S, Kamarulzaman Adeeba, Azwa Iskandar, Ng Rong-Xiang, Chong Meng-Li, Raman Nishaan, Bourne Adam
Department of Public Health, La Trobe University, Melbourne, Vic., Australia; and Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Vic., Australia; and Corresponding author. Email:
Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; and Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Sex Health. 2021 May;18(2):147-155. doi: 10.1071/SH20180.
Background By the end of 2017, an estimated 83% of people living with HIV in Malaysia knew their serostatus. However, the Ministry of Health reported a high proportion of those newly diagnosed had low CD4 counts <200 cells/µL, indicating late presentation for testing may be pervasive.
A qualitative study was conducted to explore the context and experiences of people at risk of HIV infection testing and seeking treatment later in the course of their infection. Participants recruited (n = 20) were HIV positive, aged >18 years who fit the description of late presentation (World Health Organization defined as CD4 cell count <350 cells/µL). Semi-structured interviews were conducted, and a framework approach was used to interrogate the data.
Many participants perceived themselves at low risk of HIV infection and did not undergo routine voluntary testing; rather, they were diagnosed when seeking treatment for serious illness or as part of mandatory employment-related testing. Perceived lack of confidentiality and potential discriminatory behaviour at public health facilities were significant deterrents to testing. Participants were satisfied with HIV treatment, but rarely sought psychosocial support in order to 'protect' their privacy.
Unless drivers of HIV infection are effectively addressed, including stigmatising and discriminatory practices, and low health literacy, the occurrence of late presentation will persist. Their collective impact will not only jeopardise efforts to improve the treatment cascade, but may also impact engagement with other biomedical prevention and care technologies.
背景 截至2017年底,马来西亚估计有83%的艾滋病毒感染者知晓自己的血清学状态。然而,卫生部报告称,新诊断出的患者中很大一部分CD4细胞计数较低(<200个细胞/微升),这表明晚期检测呈现有可能很普遍。
开展了一项定性研究,以探究艾滋病毒感染风险人群在感染过程后期进行检测和寻求治疗的背景及经历。招募的参与者(n = 20)为年龄超过18岁的艾滋病毒阳性者,符合晚期呈现的描述(世界卫生组织定义为CD4细胞计数<350个细胞/微升)。进行了半结构化访谈,并采用框架法对数据进行分析。
许多参与者认为自己感染艾滋病毒的风险较低,未进行常规自愿检测;相反,他们是在因重病寻求治疗时或作为与就业相关的强制检测的一部分而被诊断出来的。在公共卫生机构中,对保密性的担忧以及潜在的歧视行为是检测的重大阻碍。参与者对艾滋病毒治疗感到满意,但很少寻求心理社会支持,以便“保护”自己的隐私。
除非有效解决艾滋病毒感染的驱动因素,包括污名化和歧视行为以及健康素养低下的问题,否则晚期呈现的情况将持续存在。它们的共同影响不仅会危及改善治疗流程的努力,还可能影响对其他生物医学预防和护理技术的参与度。